100 related articles for article (PubMed ID: 5822799)
1. [Plasmapheresis as a method of production of blood fractions].
Lautner A
Bibl Haematol; 1969; 32():212-6. PubMed ID: 5822799
[No Abstract] [Full Text] [Related]
2. Plasma fractionation in England and Wales.
Vallet L
Vox Sang; 1972; 23(1):58-60. PubMed ID: 4628157
[No Abstract] [Full Text] [Related]
3. [Plasmapheresis as a method for obtaining blood derivatives in traumatology].
Lautner A
Wien Med Wochenschr; 1968 May; 118(20):469-71. PubMed ID: 5702498
[No Abstract] [Full Text] [Related]
4. New trends in plasma fractionation.
Steinbuch M
Haematologia (Budap); 1983; 16(1-4):39-51. PubMed ID: 6207083
[No Abstract] [Full Text] [Related]
5. [Plasmapheresis for the isolation of coagulating plasma fractions].
Matthes M
Folia Haematol Int Mag Klin Morphol Blutforsch; 1970; 93(3):327-33. PubMed ID: 4195277
[No Abstract] [Full Text] [Related]
6. The development of plasma derivatives in Australia.
Schiff P
Vox Sang; 1972; 23(1):38-43. PubMed ID: 4628156
[No Abstract] [Full Text] [Related]
7. Factors determining quality of plasma.
Myllylä G
Vox Sang; 1998; 74 Suppl 2():507-11. PubMed ID: 9704491
[No Abstract] [Full Text] [Related]
8. The current status of blood fractionation in the United States.
Sgouris JT
Vox Sang; 1972; 23(1):45-55. PubMed ID: 5081014
[No Abstract] [Full Text] [Related]
9. Plasma fractionation in blood transfusion service.
Haskó F; Salamon M; Bartha K; Dobó P
Dev Biol Stand; 1987; 67():39-48. PubMed ID: 3111912
[TBL] [Abstract][Full Text] [Related]
10. Current approaches to the preparation of plasma fractions.
Vandersande J
Biotechnology; 1991; 19():165-76. PubMed ID: 1786470
[No Abstract] [Full Text] [Related]
11. Notes on the production of plasma derivatives in France.
Steinbuch M
Vox Sang; 1972; 23(1):56-7. PubMed ID: 4117049
[No Abstract] [Full Text] [Related]
12. How much plasma, relative to his body weight, can a donor give over a certain period without a continuous deviation of his plasma protein metabolism in the direction of plasma protein deficiency?
Vox Sang; 1984; 47(6):435-48. PubMed ID: 6083664
[No Abstract] [Full Text] [Related]
13. New trends in plasma fractionation and plasma products.
Burnouf T
Vox Sang; 1994; 67 Suppl 3():251-3. PubMed ID: 7975504
[No Abstract] [Full Text] [Related]
14. Present state and perspectives of the farctionation of human plasma, serum and placenta.
Richter P
Ann Immunol Hung; 1973; 17():85-92. PubMed ID: 4142679
[No Abstract] [Full Text] [Related]
15. Plasma fractionation in the United States. A review for clinicians.
Ness PM; Pennington RM
JAMA; 1974 Oct; 230(2):247-50. PubMed ID: 4137885
[No Abstract] [Full Text] [Related]
16. A survey of the production of plasma derivatives for clinical use.
Schwick HG
Vox Sang; 1972; 23(1):82-91. PubMed ID: 4628158
[No Abstract] [Full Text] [Related]
17. [Advantages and disadvantages of therapeutic use of blood fractions].
Matthes M; Engbring H
Internist (Berl); 1974 Sep; 15(9):449-53. PubMed ID: 4607572
[No Abstract] [Full Text] [Related]
18. Notes on plasma derivative production in the Federal Republic of Germany.
Schwick HG
Vox Sang; 1972; 23(1):44. PubMed ID: 5081013
[No Abstract] [Full Text] [Related]
19. Which is the foreseeable future role of ethanol fractionation for the production of the main fractions albumin and immunoglobulins, as well as for the preparation of concentrates of trace proteins like coagulation factors? What is the evidence for a superior performance and practicability of other manufacturing procedures?
Vox Sang; 1981 Jan; 40(1):48-63. PubMed ID: 6784343
[No Abstract] [Full Text] [Related]
20. Technical and emotional aspects of plasmapheresis.
Becker D
Prog Clin Biol Res; 1982; 106():403-19. PubMed ID: 7178143
[No Abstract] [Full Text] [Related]
[Next] [New Search]
